相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hypomagnesemia Among Outpatient Long-Term Proton Pump Inhibitor Users
Murat Biyik et al.
AMERICAN JOURNAL OF THERAPEUTICS (2017)
The Inappropriate Prescription of Oral Proton Pump Inhibitors in the Hospital Setting: A Prospective Cross-Sectional Study
Orlaith B. Kelly et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients
Kenneth P. Chen et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
MAGNESIUM IN MAN: IMPLICATIONS FOR HEALTH AND DISEASE
Jeroen H. F. de Baaij et al.
PHYSIOLOGICAL REVIEWS (2015)
Hypomagnesemia in Hemodialysis Patients:Role of Proton Pump Inhibitors
Mohamad Alhosaini et al.
AMERICAN JOURNAL OF NEPHROLOGY (2014)
Impact of proton pump inhibitor use on magnesium homoeostasis: a cross-sectional study in a tertiary emergency department
G. Lindner et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2014)
The Association of Proton Pump Inhibitors and Hypomagnesemia in the Community Setting
Noa Markovits et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Proton-pump inhibitor use is associated with lower urinary magnesium excretion
Jeffrey H. William et al.
NEPHROLOGY (2014)
Proton Pump Inhibitors and Hospitalization with Hypomagnesemia: A Population-Based Case-Control Study
Jonathan Zipursky et al.
PLOS MEDICINE (2014)
Clinical Predictors Associated With Proton Pump Inhibitor–Induced Hypomagnesemia
Sunyong Kim et al.
AMERICAN JOURNAL OF THERAPEUTICS (2013)
Out-of-Hospital Use of Proton Pump Inhibitors and Hypomagnesemia at Hospital Admission: A Nested Case-Control Study
Ioannis Koulouridis et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Proton Pump Inhibitor-Associated Hypomagnesemia: What Do FDA Data Tell Us?
Chee Phun Luk et al.
ANNALS OF PHARMACOTHERAPY (2013)
A population-based case-control study: proton pump inhibition and risk of hip fracture by use of bisphosphonate
Joongyub Lee et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Proton-pump inhibitor use is associated with low serum magnesium concentrations
John Danziger et al.
KIDNEY INTERNATIONAL (2013)
Omeprazole enhances the colonic expression of the Mg2+ transporter TRPM6
A. L. L. Lameris et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2013)
Serum magnesium and proton-pump inhibitors use: a cross-sectional study
Gustavo Adolpho Moreira Faulhaber et al.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA (2013)
Dietary and Plasma Magnesium and Risk of Coronary Heart Disease Among Women
Stephanie E. Chiuve et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Uses of proton pump inhibitors and hypomagnesemia
Jen-Tzer Gau et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
Proton Pump Inhibitor Use and the Antifracture Efficacy of Alendronate
Bo Abrahamsen et al.
ARCHIVES OF INTERNAL MEDICINE (2011)
Low serum magnesium concentrations predict cardiovascular and all-cause mortality
Thorsten Reffelmann et al.
ATHEROSCLEROSIS (2011)
Meta-analysis: Risk of fractures with acid-suppressing medication
Chun Shing Kwok et al.
BONE (2011)
Omeprazole decreases magnesium transport across Caco-2 monolayers
Narongrit Thongon et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Lack of association between serum magnesium and the risks of hypertension and cardiovascular disease
Abigail May Khan et al.
AMERICAN HEART JOURNAL (2010)
Low serum magnesium concentrations predict increase in left ventricular mass over 5 years independently of common cardiovascular risk factors
Thorsten Reffelmann et al.
ATHEROSCLEROSIS (2010)
Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series
J. D. Mackay et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2010)
Oral Magnesium Supplementation Reduces Ambulatory Blood Pressure in Patients With Mild Hypertension
Lina S. Hatzistavri et al.
AMERICAN JOURNAL OF HYPERTENSION (2009)
Claudin-16 and claudin-19 interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium
Jianghui Hou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Severe hypomagnesaemia in long-term users of proton-pump inhibitors
T. Cundy et al.
CLINICAL ENDOCRINOLOGY (2008)
Role of the α-kinase domain in transient receptor potential melastatin 6 channel and regulation by intracellular ATP
Stephanie Thebault et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Lesson of the week - Omeprazole and refractory hypomagnesaemia
N. Shabajee et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Molecular determinants of Mg2+ and Ca2+ permeability and pH sensitivity in TRPM6 and TRPM7
Mingjiang Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement
Martin Konrad et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Proton-pump inhibitors and hypomagnesemic hypoparathyroidism
Martin Epstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Novel TRPM6 mutations in 21 families with primary hypomagnesemia and secondary Hypocalcemia
KP Schlingmann et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
TRPM6 forms the Mg2+ influx channel involved in intestinal and renal Mg2+ absorption
T Voets et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Regulation of vertebrate cellular Mg2+ Homeostasis by TRPM7
C Schmitz et al.
CELL (2003)
Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family
KP Schlingmann et al.
NATURE GENETICS (2002)
LTRPC7 is a Mg•ATP-regulated divalent cation channel required for cell viability
MJS Nadler et al.
NATURE (2001)
Magnesium transport in the gastrointestinal tract
M Schweigel et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2000)
分享论文
